F-group (family)
3016.1.1.7 Cys_Met_Meta_PP
Ligands and drugs
859
Member domains
484
with ligand contacts (≤ 4 Å)
56.3% of members
399
with DrugDomain annotations
46.4% of members
305
with a DrugBank compound
35.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3016.1.1.7 belongs to X-group 3016 C-terminal domain in some PLP-dependent transferases, which binds 8.0 ligand superclasses per 20 proteins, broader than 55% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00114 | PLP | Pyridoxal phosphate | 135 |
| DB00133 | SER | Serine | 13 |
| DB00134 | MET | Methionine | 13 |
| DB02328 | HEN | 2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid | 13 |
| DB03928 | CCO | Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol | 13 |
| DB00151 | CYS | Cysteine | 12 |
| DB04406 | PMC | 3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid | 12 |
| DB04422 | HCS | Homocysteine | 8 |
| DB00119 | PYR | Pyruvic acid | 6 |
| DB00145 | GLY | Glycine | 5 |
| DB03345 | BME | Mercaptoethanol | 3 |
| DB00123 | LYS | Lysine | 2 |
| DB02783 | IK2 | 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate | 2 |
| DB03287 | PPG | 4-(2-Amino-Ethoxy)-2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-but-3-Enoic Acid | 2 |
| DB03327 | IN5 | {1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid | 2 |
| DB04212 | NAK | 2-Iminiopropanoate | 2 |
| DB04467 | PP3 | N-(5'-phosphopyridoxyl)-L-alanine | 2 |
| DB04553 | 2KT | 2-Oxobutanoic Acid | 2 |
| DB15458 | NLE | Norleucine | 2 |
| DB02824 | PLG | N-Pyridoxyl-Glycine-5-Monophosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| PLP | PYRIDOXAL-5'-PHOSPHATE | 85 |
| 4LM | (2E)-2-{[(1E)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene]amino}but-2-enoic acid | 40 |
| NAmetal | SODIUM ION | 25 |
| TVJ | [6-methyl-4-[(~{E})-(oxamoylhydrazinylidene)methyl]-5-oxidanyl-pyridin-3-yl]methyl dihydrogen phosphate | 24 |
| WBJ | (2E)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)imino]but-3-enoic acid | 23 |
| CL | CHLORIDE ION | 19 |
| 3LM | (2E)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]-4-(methylsulfanyl)but-2-enoic acid | 15 |
| MGmetal | MAGNESIUM ION | 15 |
| SER | SERINE | 14 |
| CCO | CARBOXYMETHYLTHIO-3-(3-CHLOROPHENYL)-1,2,4-OXADIAZOL | 12 |
| HEN | 2-[(3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHYL)-IMINO]-5-PHOSPHONO-PENT-3-ENOIC ACID | 12 |
| NLE | NORLEUCINE | 12 |
| PMC | 3-(PHOSPHONOMETHYL)PYRIDINE-2-CARBOXYLIC ACID | 12 |
| E9U | (2~{S})-4-[(2~{R})-2-azanyl-3-oxidanyl-3-oxidanylidene-propyl]sulfanyl-2-[(~{E})-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylideneamino]butanoic acid | 11 |
| MET | METHIONINE | 11 |
| PY6 | 2-[O-PHOSPHONOPYRIDOXYL]-AMINO-HEXANOIC ACID | 11 |
| CYS | CYSTEINE | 10 |
| KOU | (E)-N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-L-serine | 9 |
| HCS | 2-AMINO-4-MERCAPTO-BUTYRIC ACID | 8 |
| 0JO | 2-{[(E)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene]amino}prop-2-enoic acid | 6 |